triazoles has been researched along with valganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MH; Crespo, M; Humar, A; Husain, S; Kumar, D; Manuel, O; McCurry, KR; Moussa, G; Pilewski, J; Studer, SM | 1 |
| Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A | 1 |
2 other study(ies) available for triazoles and valganciclovir
| Article | Year |
|---|---|
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
Topics: Adult; Antifungal Agents; Antiviral Agents; Bronchiolitis Obliterans; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Syndrome; Triazoles; Valganciclovir; Voriconazole | 2009 |
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Pyrimidines; Reoperation; Retrospective Studies; Survivors; Time Factors; Tissue Donors; Triazoles; Valganciclovir; Voriconazole | 2010 |